Capricor Therapeutics Inc. (NASDAQ: CAPR) Stock Information | RedChip

Capricor Therapeutics Inc. (NASDAQ: CAPR)


$12.9500
-0.1200 ( -0.39% ) 309.0K

Capricor Therapeutics Inc is a United States-based biotechnology company focused on the discovery, development, and commercialization of first-in-class biological therapies for the treatment of diseases, with a focus on Duchenne muscular dystrophy and other medical conditions. The company's development stage product pipeline includes CAP-1002, for Duchenne Muscular Dystrophy Program and COVID-19 Program; CDC-Exosomes (CAP-2003); and Exosome-mRNA vaccine.

Market Data


Open


$12.9500

Previous close


$13.0700

Volume


309.0K

Market cap


$594.29M

Day range


$12.6250 - $13.4200

52 week range


$3.5200 - $23.4000

SEC Filings


Form Type Description Pages Date
3 Insider transactions 1 Aug 23, 2024
4 Insider transactions 1 Aug 09, 2024
10-q Quarterly Reports 58 Aug 08, 2024
8-k 8K-related 15 Aug 07, 2024
8-k 8K-related 13 May 15, 2024
8-k 8K-related 14 May 15, 2024
10-q Quarterly Reports 57 May 14, 2024
8-k 8K-related 15 May 13, 2024
8-k 8K-related 42 Apr 29, 2024
4 Insider transactions 1 Apr 25, 2024

Latest News